A Credit Suisse analyst notes that the company will need to make a significant impact to meet even lowered expectations. A possible fix: more sales reps behind Belviq.
The new survey will study whether patients understand how efficacy is calculated and experiment with ways to make communications clearer.
Google's latest data shows that the doctor-patient information divide isn't so much a divide as two parts of the same conversation.
Direct-to-consumer genetic testing is controversial in part because many medical professionals and policymakers fear that it will prompt inflated perceptions of risk in patients poorly-equipped to interpret test results. A small study suggests that, at least for those administered the test through a clinical setting, that concern may be overblown.
Novo Nordisk is getting in on the boom in electronic publishing with a series of e-books available through its Cornerstones4Care patient support program.